Clinical Trial Update: Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride [Phase 1]

View source ↗

Summary

Phase 1 study assessing intra-subject variability in the bioavailability of chlorpromazine hydrochloride. The study is completed and results were posted in 2017…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Intermittent Porphyria
• Nausea and Vomiting
• Psychotic Disorders
• Schizophrenia
• Tetanus

Drugs mentioned

• CHLORPROMAZINE HYDROCHLORIDE (Chlorpromazine hydrochloride)

Snippet

Sponsor: Cycle Pharmaceuticals Ltd. | Conditions: Anti-Psychotic, Management of Manifestations of Psychotic Disorders | Phase 1 | Status: COMPLETED | Results posted: 2017-10-13